NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.88 -0.75 (-0.91%) GOLD FUTURES
2,306.20 -51.50 (-2.18%) DOW
38,018.54 -367.55 (-0.96%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
Vicarious Surgical Inc. (RBOT)
| Previous close | 0.2800 |
| Open | 0.2800 |
| Bid | 0.2950 x 1300 |
| Ask | 0.2970 x 1000 |
| Day's range | 0.2739 - 0.3028 |
| 52-week range | 0.2000 - 2.4550 |
| Volume | |
| Avg. volume | 591,646 |
| Market cap | 51.332M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Vicarious Surgical Reports First Quarter 2024 Financial Results
WALTHAM, Mass., April 29, 2024--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced financial results for the quarter ended March 31, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, April 29, 2024.
- Business Wire
Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024
WALTHAM, Mass., April 08, 2024--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2024 after the market closes on Monday, April 29, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
- Business Wire
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
WALTHAM, Mass., March 04, 2024--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter and full year ended December 31, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, March 4, 2024.
